Viral Dynamics of Omicron in Children
Viral Dynamics of the SARS-CoV-2 Omicron Variant in Paediatric Patients
1 other identifier
observational
107
1 country
1
Brief Summary
SARS-CoV-2 transmission is dependent on multiple factors, which may be related to either host-virus interaction or the environment. While there have been several studies evaluation viral dynamics and transmission risk in adults, there is limited pediatric data available. The objective of this study is to characterize the period of communicability for children less than 19 years of age with SARS-CoV-2 infection with the Omicron variant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2022
CompletedStudy Start
First participant enrolled
February 4, 2022
CompletedFirst Posted
Study publicly available on registry
February 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2022
CompletedNovember 28, 2022
November 1, 2022
2 months
February 4, 2022
November 25, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
SARS-CoV-2 Viral Load
We will use prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for individuals in the study.
10 days
Secondary Outcomes (1)
Rapid antigen test sensitivity
10 days
Interventions
Each participant will undergo daily SARS-CoV-2 PCR testing to assess viral dynamics
Eligibility Criteria
All children less than 19 years of age with acute SARS-CoV-2 infection
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
Related Publications (1)
Science M, Orkin J, Maguire B, Bitnun A, Bourns L, Corbeil A, Johnstone J, Macdonald L, Schwartz KL, Bruce Barrett C, Reinprecht J, Heisey A, Nasso S, Juni P, Campigotto A. Viral Dynamics of the SARS-CoV-2 Omicron Variant in Pediatric Patients: A Prospective Cohort Study. Clin Infect Dis. 2024 Jun 14;78(6):1506-1513. doi: 10.1093/cid/ciad740.
PMID: 38084906DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Infectious Disease Physician
Study Record Dates
First Submitted
February 4, 2022
First Posted
February 15, 2022
Study Start
February 4, 2022
Primary Completion
March 31, 2022
Study Completion
August 31, 2022
Last Updated
November 28, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share